ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Bausch Health Companies Inc

Bausch Health Companies Inc (BHC)

11,17
-0,28
(-2,45%)
Fermé 24 Novembre 10:12PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
11,17
Prix Achat
11,14
Prix Vente
11,19
Volume échangé
193 293
11,14 Fourchette du Jour 11,45
5,45 Plage de 52 semaines 15,43
Cap du marché
Clôture Veille
11,45
Ouverture
11,39
Dernière Transaction
43
@
11.17
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
356 321
Actions en circulation
365 239 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,88
Bénéfice par action (BPA)
-1,62
Chiffre d'affairess
8,76B
Bénéfice net
-592M

À propos de Bausch Health Companies Inc

Secteur
Pharmaceutical Preparations
Industrie
Drugs
Siège social
Quebec City, Quebec, Can
Fondé
1994
Bausch Health Companies Inc est coté dans le secteur Pharmaceutical Preparations de la Toronto Stock Exchange avec le ticker BHC. Le dernier cours de clôture d'Bausch Health Companies était de $11,45. Au cours de la dernière année, les actions de Bausch Health Companies ont été négociées dans une fourchette de prix de $ 5,45 à $ 15,43.

Bausch Health Companies compte actuellement 365 239 000 actions en circulation. La capitalisation boursière d'Bausch Health Companies est de $4,18 milliard. Bausch Health Companies a un ratio cours/bénéfice (ratio PE) de -6.88.

BHC Dernières nouvelles

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease PR Newswire LAVAL, QC, May 31, 2023 Cover Your Bases Campaign Kicks Off Oral Health Month with...

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION PR Newswire LAVAL, QC, Oct...

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 PR Newswire LAVAL, QC, Oct. 5, 2022 CMS Issues New Clarification...

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY PR Newswire LAVAL, QC, Oct. 3, 2022 Centers for Medicare & Medicaid Services (CMS...

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations PR Newswire LAVAL, Quebec, Sept. 28, 2022 LAVAL, Quebec, Sept. 28, 2022 /PRNewswire/ -- Bausch...

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations PR Newswire LAVAL, QC, Sept. 14, 2022 LAVAL, QC, Sept. 14, 2022 /PRNewswire/ -- Bausch Health...

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR Newswire LAVAL, QC, Sept. 9, 2022 LAVAL, QC, Sept. 9, 2022 /PRNewswire/ -- Bausch Health...

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations PR Newswire LAVAL, Quebec, Sept. 8, 2022 LAVAL, Quebec, Sept. 8, 2022 /PRNewswire/ -- Bausch...

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes PR Newswire LAVAL...

Bausch Health Continuing Process Toward Separating Bausch + Lomb

Bausch Health Continuing Process Toward Separating Bausch + Lomb PR Newswire LAVAL, QC, Aug. 22, 2022 LAVAL, QC, Aug. 22, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.1-8.9649551752212.2712.2711.1417477911.63946991CS
4-0.1-0.88731144631811.2713.7411.130862512.67415461CS
123.2641.2136536037.9113.747.935632111.10702761CS
262.2625.36475869818.9113.745.453750489.69948279CS
521.6517.33193277319.5215.435.4536138410.56089226CS
156-21.84-66.161769160933.0136.265.165063212.63177295CS
260-25.56-69.58889191436.7343.975.163903319.4736968CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AABAberdeen International Inc
$ 0,065
(18,18%)
226,54k
MDPMedexus Pharmaceuticals Inc
$ 2,45
(15,02%)
46,31k
NCFNorthcliff Resources Ltd
$ 0,04
(14,29%)
5k
SAMStarcore International Mines Ltd
$ 0,16
(14,29%)
200k
GECGlobal Education Communities Corp
$ 0,225
(12,50%)
60k
BNGBengal Energy Ltd
$ 0,005
(-50,00%)
20k
RTGRTG Mining Inc
$ 0,03
(-25,00%)
13k
SMCSulliden Mining Capital Inc
$ 0,015
(-25,00%)
200k
APSAptose Biosciences Inc
$ 0,27
(-20,59%)
346,55k
FLNTFlint Corporation
$ 0,025
(-16,67%)
28k
SUSuncor Energy Inc
$ 58,04
(0,94%)
14,14M
MFCManulife Financial Corporation
$ 45,42
(-0,53%)
9,73M
SLFSun Life Financial Inc
$ 85,54
(-0,23%)
6,19M
BITFBitfarms Ltd
$ 2,96
(3,14%)
6,17M
CNQCanadian Natural Resources Ltd
$ 48,70
(0,83%)
4,91M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock